Mark Zimmerman, MD, professor of psychiatry at Brown Medical School in Providence, Rhode Island, presented a review on controversies related to both categorizing disease severity and treatment of depression at the US Psych Congress 2018, held October 25 to 28.
According to Dr Zimmerman, “there is no clear consensus on how to conceptualize severity and there [are] no data in the literature as to how clinicians think about severity.” Determination of severity of depression affects an individual’s decision to seek treatment, the type and intensity of treatment, and whether to continue or stop treatment. Disease severity affects daily life activities, determines whether a patient qualifies for disability, and is used to monitor the efficacy of treatment…..
More from News:
Mindfulness treatment as effective as CBT for depression and anxiety
One comment on “Assessment and Treatment of Depression”
Comments are closed.